Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

Université de Montréal

$54,677.00

Clinical evaluation of surface-plasmon resonance and nanoparticle-based fluorescent detection of serum biomarkers

FY 2013-14

Summary
Our team has developed new technology that will allow the rapid detection of blood-borne disease markers, or allowmonitoring drug concentrations during treatment. Our affordable, portable prototype apparatus is based on optical detection,using recent innovations to increase sensitivity. Our innovations will allow the detection using small volumes of blood, suchthat the method is non-invasive. The technology is readily adaptable to detection of a large number of approved biomarkersand can be applied to monitoring the blood concentrations of specific drugs.This project entails the development of detection protocols for blood-borne molecules, related to cancer therapy. The focuswill be on the detection of prostate cancer, and on monitoring the course of treatment of childhood amyloid lymphoblasticleukemia. The technology developers will collaboratively adapt the detection assays to the current needs and clinical realityof clinicians from major health centers in Montreal. The assays will be rapidly integrated into clinical environments forvalidation. Our team is committed to the commercial development of this technology.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446515-2013
Name nom
Pelletier, Joelle
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
54677
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Clinical evaluation of surface-plasmon resonance and nanoparticle-based fluorescent detection of serum biomarkers
Keyword
NSERC
Application summary
Our team has developed new technology that will allow the rapid detection of blood-borne disease markers, or allowmonitoring drug concentrations during treatment. Our affordable, portable prototype apparatus is based on optical detection,using recent innovations to increase sensitivity. Our innovations will allow the detection using small volumes of blood, suchthat the method is non-invasive. The technology is readily adaptable to detection of a large number of approved biomarkersand can be applied to monitoring the blood concentrations of specific drugs.This project entails the development of detection protocols for blood-borne molecules, related to cancer therapy. The focuswill be on the detection of prostate cancer, and on monitoring the course of treatment of childhood amyloid lymphoblasticleukemia. The technology developers will collaboratively adapt the detection assays to the current needs and clinical realityof clinicians from major health centers in Montreal. The assays will be rapidly integrated into clinical environments forvalidation. Our team is committed to the commercial development of this technology.